SEC Form D · filed April 1, 2019
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Arnar Agnarsson · Bozeman, MTDirectorSaira K. Ramasastry · Raleigh, NCDirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorChristopher Long · Mission Woods, KSDirectorLorin K. Johnson · Raleigh, NCDirectorRyan Belanger-Saleh · New York, NYDirectorScott Zeilinger · New York, NYExec · DirectorShinji Kim · SAN FRANCISCO, CADirectorWilliam P. Corry · Sewickley, PADirectorRoy K. Proujansky · Raleigh, NCDirectorAnthony Maida · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorJay Madan · Raleigh, NJExec · DirectorJeffrey Myers · New York, NYDirectorJay Madan · Raleigh, NJExec · DirectorKevin Cavenaugh · Portland, ORExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗